Luye Pharma Ltd
Registered name: LUYE PHARMA LTD
Luye Pharma Ltd made £22.4m revenue and £21.8k profit in the year to 31 Dec 2025.
Luye Pharma Ltd’s revenue grew 39% to £22.4m in the year to 31 Dec 2025, with £21.8k profit and 4 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Guildford; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Guildford, South East
- Age
- 8 yrs · since 2018
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £16.2m | £16.1m | £22.4m |
| Cost of sales | £5.9m | £6.2m | £8.1m |
| Gross profit | £10.3m | £9.9m | £14.3m |
| Operating profit | £406k | £425k | £542k |
| Profit before tax | £231k | £83.9k | £28.2k |
| Profit after tax | £177k | £60k | £21.8k |
| Profit (best available) | £177k | £60k | £21.8k |
| Employees (average) | 4 | 4 | 4 |
| Ratios | |||
| Profit margin | 1.1% | 0.4% | 0.1% |
| Gross margin | 63.7% | 61.6% | 63.7% |
| Revenue per employee | £4.1m | £4m | £5.6m |
| Profit per employee | £44.2k | £15k | £5.5k |
| Growth (year on year) | |||
| Revenue growth | — | ▼0.7% | ▲39.1% |
| Profit growth | — | ▼66.1% | ▼63.6% |
| Headcount growth | — | 0% | 0% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £1.1m | £1.4m | £225k |
| Net assets | £489k | £549k | £570k |
| Fixed assets | £6.8k | £30.4k | £33.3k |
| Current assets | £10.1m | £12.9m | £17.9m |
| Debtors | £5.1m | £5.4m | £9.1m |
| Deferred income | £670k | £751k | £191k |
| Source | FullAccounts · bulk data Oct 2025 | FullAccounts · bulk data Oct 2025 | FullAccounts · bulk data Jul 2026 |
How the business works
- Profit margin
- 0.1%
- Profit ÷ revenue.
- Gross margin
- 63.7%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £5.6m
- Revenue ÷ average employees.
- Profit per employee
- £5.5k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0.1%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0.9%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 40.3%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲4%
- Now £570k
- Cash at bank
- ▼84%
- Now £225k
- Headcount
- 0%
- Now 4
- Deferred income
- ▼75%
- Now £191k
- Fixed assets
- ▲10%
- Now £33.3k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Ibsa Pharma LimitedWatford · Wholesale of pharmaceutical goods
- Revenue
- £22.5m
- Profit
- £412k
- Staff
- 49
- Agrihealth (N.i.) LimitedLurgan · Wholesale of pharmaceutical goods
- Revenue
- £22.7m
- Profit
- £1.1m
- Staff
- 60
- Mylife Diabetes Care LtdEscrick · Wholesale of pharmaceutical goods
- Revenue
- £23.5m
- Profit
- £537k
- Staff
- 39
- Paul Hartmann LimitedPilsworth Road · Wholesale of pharmaceutical goods
- Revenue
- £21.4m
- Profit
- £277k
- Staff
- 81
- GN Hearing UK LtdBicester · Wholesale of pharmaceutical goods
- Revenue
- £23.6m
- Profit
- £858k
- Staff
- 49
- Medi UK LtdWholesale of pharmaceutical goods
- Revenue
- £23.9m
- Profit
- £1.8m
- Staff
- 42
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £21.8k), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.